enGene Holdings Inc.
ENGN
$12.17
$1.5314.38%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.61% | 20.10% | 26.58% | 85.02% | 149.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 97.71% | 82.94% | 96.44% | 142.66% | 139.05% |
| Operating Income | -97.71% | -82.94% | -96.44% | -142.66% | -139.05% |
| Income Before Tax | -112.65% | 23.01% | 29.47% | 33.14% | 44.78% |
| Income Tax Expenses | 100.00% | 2,557.14% | 3,000.00% | 323.08% | -211.76% |
| Earnings from Continuing Operations | -112.73% | 22.58% | 29.26% | 33.10% | 44.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -112.73% | 22.58% | 29.26% | 33.10% | 44.81% |
| EBIT | -97.71% | -82.94% | -96.44% | -142.66% | -139.05% |
| EBITDA | -97.92% | -83.14% | -96.70% | -143.17% | -139.42% |
| EPS Basic | -52.27% | 98.40% | 98.70% | 98.88% | 98.99% |
| Normalized Basic EPS | -53.78% | 95.02% | 95.90% | 96.78% | 97.45% |
| EPS Diluted | -52.27% | 98.40% | 98.70% | 98.88% | 98.99% |
| Normalized Diluted EPS | -53.78% | 95.02% | 95.90% | 96.78% | 97.45% |
| Average Basic Shares Outstanding | 35.20% | 83.71% | 197.57% | 607.53% | 5,388.28% |
| Average Diluted Shares Outstanding | 35.20% | 83.71% | 197.57% | 607.53% | 5,388.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |